On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Journal of Clinical Investigation

• Publication date

  1991-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1172/JCI115530PMID 1752960PMCID PMC295793
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.

  1990cited by this paper
• Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor.

  1990cited by this paper
• A heparin-binding erythroid cell stimulating factor from fetal bovine serum has the N-terminal sequence of insulin-like growth factor II.

  1990cited by this paper
• Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors.

  1990cited by this paper
• Molecular Cloning and Expression of Human and Rat Tumor Necrosis Factor Receptor Chain (p60) and Its Soluble Derivative, Tumor Necrosis Factor-Binding Protein

  1990cited by this paper
• Soluble forms of tumor necrosis factor receptors (TNF‐Rs). The cDNA for the type I TNF‐R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor.

  1990cited by this paper
• Molecular cloning and expression of a receptor for human tumor necrosis factor.

  1990cited by this paper
• Isolation and characterization of a tumor necrosis factor binding protein from urine

  1989cited by this paper
• A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

  1989cited by this paper
• Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor.

  1989cited by this paper
• Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis

  1988cited by this paper
• Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses

  1988cited by this paper
• A human inhibitor of tumor necrosis factor alpha

  1988cited by this paper
• A tumor necrosis factor binding protein is present in human biological fluids

  1988cited by this paper
• Tumour necrosis factor. Polypeptide mediator network.

  1987cited by this paper
• Angiogenic factors.

  1987cited by this paper
• Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

  1987cited by this paper
• Binding of diamine oxidase activity to rat and guinea pig microvascular endothelial cells. Comparisons with lipoprotein lipase binding.

  1985cited by this paper
• Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

  1985cited by this paper
• Involvement of cell surface heparin sulfate in the binding of lipoprotein lipase to cultured bovine endothelial cells.

  1981cited by this paper
• Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system.

  1979cited by this paper
• Heparin-lipoprotein lipase interactions.

  1977cited by this paper
• An endotoxin-induced serum factor that causes necrosis of tumors.

  1975cited by this paper
• Determination of serum creatinine by a direct colorimetric method.

  1973cited by this paper
• A simple method for the determination of glomerular filtration rate.

  1972cited by this paper

• Recurrent Pregnancy Loss

  2025cites this paper
• Heparin Oligosaccharides as Vasoactive Intestinal Peptide Inhibitors via their Binding Process Characterization.

  2024cites this paper
• Comparison of heparin dressing and conventional dressing in second degree burn patients in term of pain relief and wound healing

  2022cites this paper
• Obstetric Outcomes after Recurrent Pregnancy Loss

  2020cites this paper
• Defects in Coagulation Factors Leading to Recurrent Pregnancy Loss

  2020cites this paper
• Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection

  2018cites this paper
• [Protein-losing enteropathy].

  2017cites this paper
• 8 – Complications and Adverse Sequelae of Sclerotherapy

  2017cites this paper
• Heparin and Related Substances: Physiology and Pathophysiology in General and in Human Reproduction - Part 1

  2016cites this paper
• heparins on allergic airway responses Molecular-weight-dependent effects of nonanticoagulant

  2015cites this paper
• Heparin/Heparan Sulfate Proteoglycans Glycomic Interactome in Angiogenesis: Biological Implications and Therapeutical Use

  2015cites this paper
• The Efficacy and Safety of Heparin in Patients With Sepsis: A Systematic Review and Metaanalysis*

  2015cites this paper
• Efficacy of Low Molecular Weight Heparin in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Receiving Ventilatory Support

  2014cites this paper
• Heparin-derived supersulfated disaccharide inhibits allergic airway responses in sheep.

  2014cites this paper
• Management of severe burn injuries with topical heparin: the first evidence-based study in Ghana.

  2013cites this paper
• Avaliação do potencial anti-inflamatório de composto tipo heparina (cCTH) extraído do caranguejo Goniopsis cruentata em modelo experimental de peritonite

  2013cites this paper
• Effect of oral and intravenous heparin tetrasaccharide on allergic airway responses: critical role of N-sulfation.

  2013cites this paper
• Transport and binding of tumor necrosis factor-α in articular cartilage depend on its quaternary structure.

  2013cites this paper
• Microbial heparin/heparan sulphate lyases: potential and applications

  2012cites this paper
• Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome – a retrospective propensity matched cohort study

  2012cites this paper
• The efficacy of recombinant human activated protein C (rhAPC) vs antithrombin III (at III) vs heparin, in the healing process of partial-thickness burns: a comparative study.

  2012cites this paper
• Molecular functions of syndecan-1 in disease.

  2012influential citation
• Treatment with unfractionated heparin attenuates coagulation and inflammation in endotoxemic mice.

  2011cites this paper
• Synthesis of a Library of Sulfated Small Molecules

  2011cites this paper
• 34 – Protein-Losing Enteropathy

  2011cites this paper
• Heparin and low-molecular weight heparins in thrombosis and beyond.

  2010cites this paper
• Cytokines in Blood from Septic Patients Interact With Surface-Immobilized Heparin

  2010cites this paper
• HEPARIN REDUCED MORTALITY AND SEPSIS IN SEVERELY BURNED CHILDREN

  2010cites this paper
• CB-01-05-MMX, a novel oral controlled-release low molecular weight heparin for the potential treatment of ulcerative colitis.

  2010cites this paper
• Evaluation of the Efficacy of Aspirin and Low Molecular Weight Heparin in Patients with Unexplained Recurrent Spontaneous Abortions

  2010cites this paper
• Interactions of Mast Cells with the Lymphatic System: Delivery of Peripheral Signals to Lymph Nodes by Mast Cell-Derived Particles

  2009cites this paper
• Emerging Links Between Thrombosis, Inflammation, and Angiogenesis: Key Role of Heparin and Low-Molecular-Weight Heparins

  2009cites this paper
• The heparanome and regulation of cell function: structures, functions and challenges.

  2008cites this paper
• Identification of the heparin-binding domain of TNF-alpha and its use for efficient TNF-alpha purification by heparin-Sepharose affinity chromatography.

  2008cites this paper
• Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function.

  2008cites this paper
• Carbohydrate Recognition by Cytokines and Its Relevance to Their Physiological Activities

  2008cites this paper
• Early intravenous unfractionated heparin and mortality in septic shock*

  2008cites this paper
• Designing Non-saccharide Heparin/Heparan Sulfate Mimics

  2008cites this paper
• Nadroparine Blunts Lipopolysaccharide-Induced Hypothermia and Behavioral Depression in Mice

  2008cites this paper
• Syndecan-1 Is an in Vivo Suppressor of Gram-positive Toxic Shock*

  2008cites this paper
• Complications and Adverse Sequelae of Sclerotherapy

  2007cites this paper
• Heparin reduced mortality and sepsis in severely burned children.

  2007cites this paper
• Recurrent spontaneous abortions in antiphospholipid syndrome: natural killer cells - an additional mechanism in a multi factorial process.

  2007cites this paper
• Heparin, Low Molecular Weight Heparin, and Derivatives in Thrombosis, Angiogenesis, and Inflammation: Emerging Links

  2007cites this paper
• Caractérisation des interactions glycosaminoglycannes/protéines dans le but de développer des molécules d'intérêt thérapeutique : exemples de l'Endocan et de l'interféron gamma

  2007cites this paper
• Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey.

  2006cites this paper
• Interleukin-lßInduces Interleukin-1 Receptor Antagonist and Tumor Necrosis Factor Binding Protein in Humans1

  2006cites this paper
• Serglycin Is the Major Secreted Proteoglycan in Macrophages and Has a Role in the Regulation of Macrophage Tumor Necrosis Factor-α Secretion in Response to Lipopolysaccharide*

  2006cites this paper
• AMELIORATIVE EFFECT OF MELATONIN ON HISTOPATHOLOGICAL ALTERATIONS-INDUCED BY CARBON TETRACHLORIDE IN WISTAR RATS

  2006cites this paper
• Thrombophilia and recurrent pregnancy loss.

  2006cites this paper
• Applied glycoproteomics--approaches to study genetic-environmental collisions causing protein-losing enteropathy.

  2006cites this paper
• Heparan Sulfate Plays a Central Role in a Dynamic in Vitro Model of Protein-losing Enteropathy*

  2006cites this paper
• Heparin Displaces Interferon-&ggr;–Inducible Chemokines (IP-10, I-TAC, and Mig) Sequestered in the Vasculature and Inhibits the Transendothelial Migration and Arterial Recruitment of T Cells

  2006cites this paper
• Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy.

  2005influential citation
• Emerging Links between Thrombosis, Inflammation and Cancer: Role of Heparin

  2005cites this paper
• Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-α antibody

  2005cites this paper
• Heparin and Low Molecular Weight Heparin in Thrombosis and Inflammation: Emerging Links

  2005cites this paper
• Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes.

  2004cites this paper
• Cytokines in recurrent miscarriage

  2004cites this paper
• Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity

  2004cites this paper
• Linear basic peptides for targeting interferon-gamma-glycosaminoglycan interactions: synthesis and inhibitory properties.

  2004cites this paper
• Heparin improves organ microcirculatory disturbances in caerulein-induced acute pancreatitis in rats.

  2004cites this paper
• Biologische Therapie chronisch-entzündlicher Darmerkrankungen

  2003cites this paper
• [Biologic therapy of inflammatory bowel disease].

  2003cites this paper
• Benzylpenicillin differentially conjugates to IFN‐γ, TNF‐α, IL‐1β, IL‐4 and IL‐13 but selectively reduces IFN‐γ activity

  2003cites this paper
• Benzylpenicillin differentially conjugates to IFN-gamma, TNF-alpha, IL-1beta, IL-4 and IL-13 but selectively reduces IFN-gamma activity.

  2003cites this paper
• Protective effect of low molecular weight heparin on experimental colitis: role of neutrophil recruitment and TNF-α production

  2002cites this paper
• Gerinnungssystem und chronisch entzündliche Darmerkrankungen: Therapeutische und pathophysiologische Implikationen

  2002cites this paper
• Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor‐α release in preeclampsia

  2002cites this paper
• Adsorption of inflammatory cytokines using a heparin-coated extracorporeal circuit.

  2002cites this paper
• Increased in Vitro Cytotoxicity of TNF‐α Analog LK‐805 Is Based on the Interaction with Cell Surface Heparan Sulfate Proteoglycan

  2002cites this paper
• [Coagulation system and inflammatory bowel disease: therapeutic and pathophysiologic implications].

  2002cites this paper
• Protective effect of low molecular weight heparin on experimental colitis: role of neutrophil recruitment and TNF-alpha production.

  2002cites this paper
• Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model

  2002cites this paper
• Heparin in the treatment of burns: a review.

  2001influential citation
• Overexpression of EXTL3/EXTR1 enhances NF-κB activity induced by TNF-α

  2001cites this paper
• Tumor Necrosis Factor-Dependent Adhesions as a Major Protective Mechanism Early in Septic Peritonitis in Mice

  2001cites this paper
• Inability of plasma high-density lipoproteins to inhibit cell adhesion molecule expression in human coronary artery endothelial cells.

  2001cites this paper
• Overexpression of EXTL3/EXTR1 enhances NF-kappaB activity induced by TNF-alpha.

  2001cites this paper
• Heparin and low‐molecular‐weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats

  2001cites this paper
• Low-Dose Low-Molecular Weight Heparin (Enoxaparin) Is Effective as Adjuvant Treatment in Active Ulcerative Colitis: An Open Trial

  2001cites this paper
• Gerinnungssystem und chronisch entzündliche Darmerkrankungen

  2001cites this paper
• Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides.

  2000cites this paper
• Heparin attenuates TNF-α induced inflammatory response through a CD11b dependent mechanism

  2000cites this paper
• Detection of membrane‐bound tumor necrosis factor (TNF): An analysis of TNF‐specific reagents

  2000cites this paper
• Potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease

  2000cites this paper
• Dexamethasone differentially regulates cytokine transcription and translation in macrophages responding to bacteria or okadaic acid.

  1999cites this paper
• Molecular-weight-dependent effects of nonanticoagulant heparins on allergic airway responses.

  1999cites this paper
• Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease

  1999cites this paper
• Binding of interferon gamma by glycosaminoglycans: a strategy for localization and/or inhibition of its activity.

  1999cites this paper
• Glycosaminoglycans prevent the functional and morphological peritoneal derangement in an experimental model of peritoneal fibrosis.

  1999cites this paper
• Soluble cytokine receptors: basic immunology and clinical applications.

  1999cites this paper
• The Inflammatory Effect of Coagulation and the Antiinflammatory Effect of Anticoagulation in Sepsis and Shock

  1999cites this paper
• The effect of heparin on trinitrobenzene sulphonic acid‐induced colitis in the rat

  1998cites this paper
• Anticoagulation for continuous renal replacement therapies

  1998cites this paper
• Low molecular weight heparin is associated with greater cytokine production in a stimulated whole blood model.

  1998cites this paper
• Endothelial Cell Contact Potentiates Release of Soluble Tumor Necrosis Factor (TNF) Receptors from the Monocyte-like Cell Line THP-1

  1998influential citation
• LOW MOLECULAR WEIGHT HEPARIN PREVENTS THE PULMONARY HEMODYNAMIC AND PATHOMORPHOLOGIC EFFECTS OF ENDOTOXIN IN A PORCINE ACUTE LUNG INJURY MODEL

  1998cites this paper
• Histamine content and secretion in basophils and mast cells.

  1998cites this paper
• Age-Dependent Levels of Select Immunological Mediators in Sera of Healthy Children

  1998cites this paper